LIPID-LOWERING THERAPY WITH PCSK9 INHIBITORS: FAMILIAL HYPERCHOLESTEROLEMIA VS GENERAL POPULATION OUTCOMES

被引：0
|
作者：
Matteucci, A. [1 ]
Alonzo, A. [1 ]
Castello, L. [1 ]
Spinelli, A. [1 ]
Marino, G. [1 ]
Schiaffini, G. [1 ]
Di Fusco, S. [1 ]
Aquilani, S. [1 ]
Aiello, A. [1 ]
Colivicchi, F. [1 ]
机构：
[1] San Filippo Neri, Rome, Italy
来源：
EUROPEAN HEART JOURNAL SUPPLEMENTS | 2024年 / 26卷
关键词：
D O I：
10.1093/eurheartjsupp/suae036.314
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
suae036.31
引用
收藏
页数：1
相关论文
共 50 条
  • [1] LDL-cholesterol and PCSK9 in patients with familial hypercholesterolemia: influence of PCSK9 variants under lipid-lowering therapy
    Hamasaki, Masato
    Sakane, Naoki
    Hara, Kazuo
    Kotani, Kazuhiko
    [J]. JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2021, 35 (11)
  • [2] Statins and PCSK9 inhibitors: A new lipid-lowering therapy
    Gallego-Colon, Enrique
    Daum, Aner
    Yosefy, Chaim
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2020, 878
  • [3] Recent advances in developing PCSK9 inhibitors for lipid-lowering therapy
    Lavecchia, Antonio
    Cerchia, Carmen
    [J]. FUTURE MEDICINAL CHEMISTRY, 2019, 11 (05) : 423 - 441
  • [4] PCSK9 inhibitors: an overview on a new promising lipid-lowering therapy
    Denegri, Andrea
    Petrova-Slater, Iveta
    Pasotti, Elena
    Rossi, Maria Grazia
    Pedrazzini, Giovanni Battista
    Moccetti, Tiziano
    Moccetti, Marco
    [J]. JOURNAL OF CARDIOVASCULAR MEDICINE, 2016, 17 (04) : 237 - 244
  • [5] Management of lipid-lowering therapy in PCSK9 inhibitors-treated patients
    Aretio, Ana
    Campos-Baeta, Ylenia
    Feliu, Anna
    Masip, Montserrat
    Mangues, Ma Antonia
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2018, 40 (01) : 247 - 248
  • [6] Lipid-lowering drugs and PCSK9
    Millan Nunez-Cortes, Jesus
    Mostaza Prieto, Jose M.
    [J]. CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2016, 28 : 9 - 13
  • [7] PCSK9 Inhibitors for Familial Hypercholesterolemia
    Lenahan, Christy M.
    Harringtoon, Deedra
    [J]. JNP-JOURNAL FOR NURSE PRACTITIONERS, 2016, 12 (08): : 577 - 578
  • [8] PCSK9 Inhibitors: A New Era in Lipid-Lowering Treatment?
    Cainzos-Achirica, Miguel
    Martin, Seth S.
    Cornell, John E.
    Murow, Cynthia D.
    Guallar, Eliseo
    [J]. ANNALS OF INTERNAL MEDICINE, 2015, 163 (01) : 64 - 65
  • [9] Economic evaluation of lipid lowering with PCSK9 inhibitors in patients with familial hypercholesterolemia: Methodological aspects
    Wisloff, Torbjorn
    Mundal, Liv J.
    Retterstol, Kjetil
    Igland, Jannicke
    Kristiansen, Ivar Sonbo
    [J]. ATHEROSCLEROSIS, 2019, 287 : 140 - 146
  • [10] Lipid lowering with PCSK9 inhibitors
    Razvan T. Dadu
    Christie M. Ballantyne
    [J]. Nature Reviews Cardiology, 2014, 11 : 563 - 575
12345